KALA BIO, Inc.
NASDAQKALA BIO enters the week after one of the most violent drawdowns in the small-cap biotech universe — down 74% over the past month, down 26% in the last five days alone, and trading at $2.93 after a 1-for-50 reverse stock split took effect on May 11. The reverse split is the central fact of the week. KALA executed a 1-for-50 consolidation effective May 11, a move that mechanically…
KALA short interest tumbled 26.6% over the past week to 9.26% of float, as cost to borrow fell to 15.95% from elevated levels.
Snapshot as of 30 Jun 2026
KALA BIO enters the week after one of the most violent drawdowns in the small-cap biotech universe — down 74% over the past month, down 26% in the last five days alone, and trading at $2.93 after a 1-for-50 reverse…
KALA BIO enters its May 19 Q1 results having lost nearly three-quarters of its value over the past month — a collapse that changes what Monday's print is actually about. The price action alone frames the setup. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for KALA — free to start on ORTEX.
Sign up for free →Open KALA on ORTEX